Discovery of a Novel FGFR4 Selective Inhibitor via Structure-Activity Relationship Studies of FGF401

doi:10.6023/cjoc201904073

Chinese Journal of Organic Chemistry ›› 2020, Vol. 40 ›› Issue (1): 84-94.DOI: 10.6023/cjoc201904073 Previous Articles Next Articles

通过FGF401的构效关系研究发现一种新颖的FGFR4选择性抑制剂

孙长安, 房雷, 苟少华

东南大学化学化工学院江苏省生物药物高技术研究重点实验室南京 211189

收稿日期:2019-04-29 修回日期:2019-08-31 发布日期:2019-09-18
通讯作者: 苟少华, 房雷 E-mail:sgou@seu.edu.cn;lei.fang@seu.edu.cn
基金资助:
江苏省高等学校优势学科发展基金（No.1107047002）和国家科技重大专项基金（No.2013ZX09402102-001-006）资助项目.

Discovery of a Novel FGFR4 Selective Inhibitor via Structure-Activity Relationship Studies of FGF401

Sun Chang'an, Fang Lei, Gou Shaohua

Jiangsu Province Hi-Tech Key Laboratory for Bio-medical Research and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189

Received:2019-04-29 Revised:2019-08-31 Published:2019-09-18
Supported by:
Project supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 1107047002) and the National Science and Technology Major Foundation of China (No. 2013ZX09402102-001-006).

1. 200084S.pdf.pdf(1369KB)

Abstract

A set of analogues of FRF401 were designed and synthesized, and their FGFR4 inhibition and antitumor activity as well as the structure-activity relationship (SAR) studies were screened. It was found that N-(5-cyano-4-((2-methoxyethyl)-amino)pyridin-2-yl)-7-formyl-6-((N-methyltetrahydro-2H-pyran-4-carboxamido)methyl)-1,2,3,4-tetrahydro-1,8-naphthyridine-1-carboxamide (8ac) not only showed superior FGFR4 inhibitory activity compared with FGF401 and excellent selectivity in enzymatic and cellular level, but also dramatically inhibited tumor growth and induced tumor regression in hepatocellular carcinoma xenograft model.

Key words: selective FGFR4 inhibitor, analogues of FRF401, structure-activity relationship, hepatocellular carcinoma

Cite this article

Sun Chang'an, Fang Lei, Gou Shaohua. Discovery of a Novel FGFR4 Selective Inhibitor via Structure-Activity Relationship Studies of FGF401[J]. Chinese Journal of Organic Chemistry, 2020, 40(1): 84-94.

Export EndNote|Reference Manager|ProCite|BibTeX|RefWorks

share this article

References

[1] Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre L. A.; Jemal A. CA:Cancer J. Clin. 2018, 68, 394.
[2] Keating, G. M.; Santoro, A. Drugs 2009, 69, 223.
[3] US Food and Drug Administration Approved Drugs-FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma, Published Online:Aug 16, 2018. https://www.fda.gov/drugs/resources-infor-mation-approved-drugs/fda-approves-lenvatinib-unresectable-hepa-tocellular-carcinoma(accessed Jan 19, 2020).
[4] Ho, H. K.; Pok, S.; Streit, S.; Ruhe, J. E.; Hart, S.; Lim, K. S.; Loo, H. L.; Aung, M. O.; Lim, S. G.; Ullrich, A. J. Hepatol. 2009, 50, 118.
[5] Sawey, E. T.; Chanrion, M.; Cai, C. L.; Wu, G. M.; Zhang, J. P.; Zender, L.; Zhao, A.; Busuttil, R. W.; Yee, H. M.; Stein, L.; French, D. M.; Finn, R. S.; Lowe, S. W.; Powers, S. Cancer Cell 2011, 19, 347.
[6] Hyeon, J.; Ahn, S.; Lee, J. J.; Song, D. H.; Park, C. K. Dig. Dis. Sci. 2013, 58, 1916.
[7] Pinyol, R.; Nault, J. C.; Quetglas, I. M.; Zucman-Rossi, J.; Llovet, J. M. Semin. Liver Dis. 2014, 34, 363.
[8] Tucker, J. A.; Klein, T.; Breed, J.; Overman, R.; Phillips, C.; Norman, R. A. Structure 2014, 22, 1764.
[9] Llovet, J. M.; Villanueva, A.; Lachenmayer, A.; Finn, R. S. Nat. Rev. Clin. Oncol. 2015, 12, 408.
[10] Repana, D.; Ross, P. Diseases 2015, 3, 294.
[11] Lu, X. Y.; Chen, H.; Patterson, A. V.; Smaill, J. B.; Ding, K. J. Med. Chem. 2019, 62, 2905.
[12] Hagel, M.; Miduturu, C.; Sheets, M.; Rubin, N.; Weng, W.; Stransky, N.; Bifulco, N.; Kim, J. L.; Hodous, B.; Brooijmans, N.; Shutes, A.; Winter, C.; Lengauer, C.; Kohl, N. E.; Guzi, T. Cancer Discovery 2015, 5, 424.
[13] Joshi, J. J.; Coffey, H.; Corcoran, E.; Tsai, J.; Huang, C. L.; Ichikawa, K.; Prajapati, S.; Hao, M. H.; Bailey, S.; Wu, J. Cancer Res. 2017, 77, 6999.
[14] Mo, C.; Zhang, Z.; Guise, C. P.; Li, X.; Luo, J.; Tu, Z.; Xu, Y.; Patterson, A. V.; Smaill, J. B.; Ren, X. ACS Med. Chem. Lett. 2017, 8, 543.
[15] Wang, Y.; Chen, Z.; Dai, M.; Sun, P.; Wang, C.; Gao, Y.; Zhao, H.; Zeng, W.; Shen, L.; Mao, W. Bioorg Med. Chem. Lett. 2017, 27, 2420.
[16] Knoepfel, T.; Furet, P.; Mah, R.; Buschmann, N.; Leblanc, C.; Ripoche, S.; Graus-Porta, D.; Wartmann, M.; Galuba, I.; Fairhurst, R. A. ACS Med. Chem. Lett. 2018, 9, 215.
[17] Yasuda, N.; Hsiao, Y.; Jensen, M. S.; Rivera, N. R.; Yang, C. H.; Wells, K. M.; Yau, J.; Palucki, M.; Tan, L. S.; Dormer, P. G.; Volante, R. P.; Hughes, D. L.; Reider, P. J. J. Org. Chem. 2004, 69, 1959.
[18] Novartis, A. G.; Buschmann, N.; Fairhurst, R. A.; Furet, P.; Knöpfel, T.; Leblanc, C.; Liao, L.; Wang, C.; Zhao, X. L. US 2015/119385, 2015.

通过FGF401的构效关系研究发现一种新颖的FGFR4选择性抑制剂

Discovery of a Novel FGFR4 Selective Inhibitor via Structure-Activity Relationship Studies of FGF401

PDF

Supporting Info.

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Haibo Huo, Guixia Li, Shijun Wang, Chun Han, Baojun Shi, Jian Li. Novel γ-Carboline Derivatives as Antibacterial Agents: Synthesis and Antibacterial Evaluation [J]. Chinese Journal of Organic Chemistry, 2024, 44(1): 204-215.
[2]	Xin Zuo, Shinuo Xu, Zhongyang Chen, Jianfeng Yan, Yaofeng Yuan. Research Progress of Electron Transport Properties in Ferrocene- Containing Single-Molecule Junctions [J]. Chinese Journal of Organic Chemistry, 2023, 43(7): 2313-2322.
[3]	Jinyan He, Fuyun Tian, Qingqing Wu, Yueming Zheng, Yuting Chen, Haiyan Xu, Zhengsheng Jin, Li Zhan, Xinqiang Cheng, Yueling Gu, Zhaobing Gao, Guilong Zhao. Design, Synthesis and Bioactivity of [3.3.3]Propellane-Based Voltage-Gated Calcium Channel α2δ Subunit Ligands [J]. Chinese Journal of Organic Chemistry, 2023, 43(6): 2226-2238.
[4]	Xingzhou Liu, Mingjia Yu, Jianhua Liang. Research Progress on the Synthesis of Protoberberine Skeleton and Its Anti-inflammatory Activity [J]. Chinese Journal of Organic Chemistry, 2023, 43(4): 1325-1340.
[5]	Rong Zhang, Xiang Gao, Lingling Chen, Fajun Nan. Discovery and Structure-Activity Relationship Studies of Thiazole- Oxazole Tandem Heterocyclic RNA Splicing Inhibitors [J]. Chinese Journal of Organic Chemistry, 2022, 42(9): 2925-2939.
[6]	Ming Cai, Liang Shao, Fan Yang, Jihong Zhang, Fei Yu. Design, Synthesis of Pentacyclic Triterpenoid Glucose Conjugate and in vitro Activity against Influenza Virus [J]. Chinese Journal of Organic Chemistry, 2022, 42(5): 1453-1462.
[7]	Siyu Zhu, Xinyu Huo, Qin Ma, Wei Chen, Jie Zhang, Liang Guo. Design, Synthesis, and Antitumor Activity of β-Carboline-Benzimidazole Hybrids [J]. Chinese Journal of Organic Chemistry, 2022, 42(4): 1129-1135.
[8]	Yuanfang Kong, Bin Yang, Yan Zhuang, Jingyu Zhang, Demei Sun, Chunhong Dong. Research Progress on the Synthesis and Structure-Activity Relationship of Five Hypoglycemic Active Heterocycles Based on Dipeptidyl Peptidase 4 (DPP-4) Target Design [J]. Chinese Journal of Organic Chemistry, 2022, 42(3): 770-784.
[9]	Yan Zeng, Lifei Nie, Chao Niu, Aytilla Mamatjan, Khurshed Bozorov, Jiangyu Zhao, Haji Akber Aisa. Synthesis and Biological Activities of Dihydrooxazolo[5,4-d]-pyrrolo[1,2-a]pyrimidinones [J]. Chinese Journal of Organic Chemistry, 2022, 42(2): 543-556.
[10]	Wei Wang, Furan Wu, Yidan Ma, Dan Xu, Gong Xu. Study on Synthesis and Antifungal Activity of Novel Benzamides Containing Substituted Pyrazole Unit [J]. Chinese Journal of Organic Chemistry, 2022, 42(2): 607-618.
[11]	Lijie Yu, Bo Feng, Zhijia Wang, Lixin Gao, Chun Zhang, Rajendran Satheeshkumar, Jia Li, Yubo Zhou, Wenlong Wang. Synthesis of 5-Phenyl-1,3,4-thiadiazole Derivatives and Their Biochemical Evaluation against Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 1 (SHP1) [J]. Chinese Journal of Organic Chemistry, 2021, 41(8): 3097-3105.
[12]	Hang Liu, Shuyun Zhang, Huan Li, Yan Zhang, Zhengming Li, Baolei Wang. Synthesis and Biological Activities of Novel 8-((3,4,4-Trifluorobut-3-en-1-yl)thio)-substituted Methylxanthines and Their Derivatives [J]. Chinese Journal of Organic Chemistry, 2021, 41(5): 2091-2098.
[13]	Ding Ma, Junli Ao, Naifeng Hu, Guangxin Liang. Progress in Biological Activity and Synthesis of Nematode Hatching Pheromone Glycinoeclepin A [J]. Chinese Journal of Organic Chemistry, 2021, 41(2): 553-566.
[14]	Yue Sun, Liang Guo, Wenxi Fan, Wei Chen, Jie Zhang, Bin Dai. Synthesis, Crystal Structure and Antitumor Activity of Novel 5-Chloro-β-carboline Derivatives [J]. Chinese Journal of Organic Chemistry, 2021, 41(1): 400-406.
[15]	Shao Lihui, Gan Yiyuan, Hou Mi, Tao Shilin, Zhang Liqiong, Wang Zhenchao, Ouyang Guiping. Design, Synthesis and Biological Activity of Quinazolinone Derivatives Containing Hydrazone Structural Units [J]. Chinese Journal of Organic Chemistry, 2020, 40(7): 1975-1982.